Related Experiment Video
Updated: Sep 2, 2025

04:49
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
Published on: July 5, 2024
1.2K
Insulin and Zinc Co-Administration Ameliorate Diabetes Mellitus-Induced Reproductive Dysfunction in Male Rats
G Ujah1, I B Emmanuel2, F Ansa3
1University of Calabar, Calabar. gasukole@yahoo.com.
Summary
Co-administering insulin and zinc significantly improved male reproductive function in diabetic rats compared to individual treatments. This combination therapy offers a promising approach to ameliorate diabetes-induced reproductive dysfunction.
Area of Science:
- Reproductive Endocrinology
- Metabolic Disorders
- Toxicology
Background:
- Diabetes mellitus (DM) is a significant cause of male reproductive dysfunction.
- The therapeutic potential of combined insulin and zinc for diabetic male reproductive issues remains unclear.
Purpose of the Study:
- To investigate if co-administering insulin and zinc improves male reproductive dysfunction in diabetic rats.
- To compare the efficacy of combined therapy versus individual insulin or zinc treatment.
Main Methods:
- Five groups of rats (normal and diabetic) were used, including untreated diabetic controls.
- Diabetic rats received insulin, zinc, or a combination of both for ten days.
- Reproductive parameters, hormone levels, and testicular morphology were analyzed post-treatment.
Main Results:
- Diabetes mellitus (DM) reduced sperm count, motility, viability, normal sperm cells, semen pH, and key reproductive hormones (FSH, LH, testosterone).
- DM increased sperm cells with defective tails and impaired testicular morphology.
- Combined insulin and zinc treatment notably improved sperm viability, Sertoli cell count, Johnsen's score, reproductive hormones, and semen pH.
Conclusions:
- Both insulin and zinc individually ameliorated some aspects of DM-induced male sexual dysfunction.
- Co-administration of insulin and zinc demonstrated superior efficacy in reversing reproductive impairments caused by DM.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
236
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
236
Oral Hypoglycemic Agents: Biguanides and Glitazones
275
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
275
The Endocrine System
517
The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that...
517

